Holen Sie sich die Stockscreener-App
21.84
1.04%
-0.225
Handel nachbörslich:
21.82
-0.015
-0.07%
Schlusskurs vom Vortag:
$22.06
Offen:
$22.07
24-Stunden-Volumen:
2.85M
Relative Volume:
0.35
Marktkapitalisierung:
$15.05B
Einnahmen:
$2.87B
Nettoeinkommen (Verlust:
$250.10M
KGV:
68.49
EPS:
0.3188
Netto-Cashflow:
$1.13B
1W Leistung:
-1.98%
1M Leistung:
+2.01%
6M Leistung:
+26.62%
1J Leistung:
+28.87%
1-Tages-Spanne:
$21.68
$22.18
1-Wochen-Bereich:
$21.68
$22.95
52-Wochen-Spanne:
$15.70
$22.95
Healthpeak Properties Inc Stock (DOC) Company Profile
Firmenname
Healthpeak Properties Inc
Sektor
Telefon
949-407-0700
Adresse
4600 SOUTH SYRACUSE STREET, DENVER, WI
Compare DOC vs WELL, VTR, OHI, AHR
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
DOC
Healthpeak Properties Inc
|
21.83 | 15.53B | 2.87B | 250.10M | 1.13B | 0.3188 |
WELL
Welltower Inc
|
234.86 | 175.31B | 11.75B | 1.46B | 2.19B | -0.6014 |
VTR
Ventas Inc
|
93.58 | 48.67B | 6.13B | 272.21M | 1.38B | 0.5521 |
OHI
Omega Healthcare Investors Inc
|
50.65 | 15.31B | 1.24B | 655.98M | 857.80M | 2.063 |
AHR
American Healthcare Reit Inc
|
55.62 | 11.07B | 2.37B | 101.67M | 169.19M | 0.5775 |
Healthpeak Properties Inc Stock (DOC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-04-20 | Eingeleitet | UBS | Neutral |
| 2026-02-05 | Herabstufung | Argus | Buy → Hold |
| 2026-01-09 | Eingeleitet | Goldman | Neutral |
| 2025-12-16 | Herabstufung | Jefferies | Buy → Hold |
| 2025-10-01 | Eingeleitet | Cantor Fitzgerald | Neutral |
| 2025-09-15 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2025-08-20 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2025-07-29 | Herabstufung | Scotiabank | Sector Outperform → Sector Perform |
| 2025-01-15 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2024-10-21 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2024-05-03 | Hochstufung | Wedbush | Neutral → Outperform |
| 2024-04-26 | Hochstufung | Exane BNP Paribas | Neutral → Outperform |
| 2024-04-22 | Fortgesetzt | Mizuho | Buy |
| 2024-04-01 | Hochstufung | BofA Securities | Underperform → Buy |
| 2024-03-25 | Fortgesetzt | Wells Fargo | Equal Weight |
| 2024-03-08 | Fortgesetzt | RBC Capital Mkts | Outperform |
| 2024-01-05 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-05-26 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2023-04-20 | Eingeleitet | Wells Fargo | Underweight |
| 2022-12-14 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2022-10-28 | Eingeleitet | JP Morgan | Neutral |
| 2022-08-05 | Herabstufung | Colliers Securities | Buy → Neutral |
| 2022-06-03 | Eingeleitet | CapitalOne | Equal Weight |
| 2022-05-19 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2022-04-26 | Eingeleitet | Barclays | Overweight |
| 2022-02-01 | Eingeleitet | Credit Suisse | Neutral |
| 2022-01-07 | Herabstufung | BMO Capital Markets | Outperform → Market Perform |
| 2021-09-13 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-08-20 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2021-06-14 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2021-03-15 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2021-01-13 | Hochstufung | Jefferies | Hold → Buy |
| 2020-12-14 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2020-11-11 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2020-09-30 | Fortgesetzt | Robert W. Baird | Outperform |
| 2020-09-02 | Fortgesetzt | Stifel | Buy |
| 2020-04-07 | Herabstufung | Citigroup | Buy → Neutral |
| 2020-04-01 | Hochstufung | Berenberg | Hold → Buy |
| 2020-03-16 | Herabstufung | BTIG Research | Buy → Neutral |
| 2020-03-09 | Hochstufung | BMO Capital Markets | Market Perform → Outperform |
| 2020-02-27 | Hochstufung | CapitalOne | Equal Weight → Overweight |
| 2019-12-20 | Eingeleitet | Mizuho | Buy |
| 2019-12-12 | Hochstufung | Citigroup | Neutral → Buy |
| 2019-11-26 | Hochstufung | Stifel | Hold → Buy |
| 2019-10-14 | Eingeleitet | BofA/Merrill | Neutral |
| 2019-06-20 | Eingeleitet | Citigroup | Neutral |
| 2019-05-02 | Herabstufung | CapitalOne | Overweight → Equal Weight |
| 2018-08-03 | Hochstufung | CapitalOne | Equal Weight → Overweight |
| 2018-04-25 | Herabstufung | Stifel | Buy → Hold |
| 2018-03-01 | Bestätigt | B. Riley FBR, Inc. | Buy |
| 2018-01-05 | Bestätigt | Robert W. Baird | Outperform |
| 2017-11-06 | Hochstufung | Hilliard Lyons | Long-term Buy → Buy |
Alle ansehen
Healthpeak Properties Inc Aktie (DOC) Neueste Nachrichten
Healthpeak Properties Inc. stock outperforms competitors on strong trading day - MarketWatch
BMO Capital Adjusts Price Target on Healthpeak Properties to $25 From $24, Maintains Outperform Rating - marketscreener.com
Healthpeak Properties, Inc. Revenue Breakdown – BMV:DOC - TradingView
Healthpeak Properties (DOC) Rebound Puts Its Fair Value Debate Back In Focus - simplywall.st
PEAK5302933 Bond Profile — Key Metrics - TradingView
PEAK5302933 Bond Risk Profile - TradingView
HCP Changes Name to Healthpeak Properties - Nareit
Healthpeak Properties (NYSE:DOC) Faces A Valuation Split - Kalkine Media
Analysts Conflicted on These Real Estate Names: Healthpeak Properties (DOC) and Blackstone Mortgage (BXMT) - The Globe and Mail
Healthpeak Properties Inc. stock outperforms competitors despite losses on the day - MarketWatch
JPMorgan Chase (NYSE: JPM) discloses 4.3% beneficial stake in Healthpeak Properties - Stock Titan
Latham & Watkins Represents Healthpeak Properties in a US$2.1 Billion Strategic Joint Venture With Brookfield Asset Management - Legal Desire Media and Insights
Latham Watkins Represents Healthpeak Properties in a Strategic Joint Venture With Brookfield - Latham & Watkins LLP
PEAK5214875 Bond Risk Profile - TradingView
Evercore ISI Adjusts Price Target on Healthpeak Properties to $23 From $21, Maintains In Line Rating - Moomoo
Brookfield picks up stake in Healthpeak’s $2B medical office venture - The Real Deal
Brookfield Asset Management (TSX:BAM) Partners With Healthpeak On $2.1 Billion Medical Buildings Venture - Yahoo Finance
Healthpeak & Brookfield Form Outpatient Medical Joint Venture - Yahoo Finance
JPMorgan Adjusts Price Target on Healthpeak Properties to $22 From $21, Maintains Neutral Rating - marketscreener.com
Healthpeak, Brookfield form $2.1bn outpatient medical joint venture - Alternatives Watch
Healthpeak Properties (DOC) Secures $1.025B from Joint Venture w - GuruFocus
Barclays Maintains Healthpeak Properties(DOC.US) With Hold Rating, Maintains Target Price $23 - Moomoo
Healthpeak, Brookfield Launch $2.1B Outpatient CRE Venture - Yahoo Finance
Healthpeak Properties' Q2 2026 earnings: What to expect - MSN
Brookfield Asset Management forms joint venture with US REIT Healthpeak Properties - MSN
Brookfield Asset Management Ltd. and its affiliates acquired 49% stake in Portfolio of Outpatient Medical Buildings Across the United States from Healthpeak Properties, Inc. for approximately $1 billion. - marketscreener.com
Brookfield Asset Management forms joint venture with U.S. REIT Healthpeak Properties - BNN Bloomberg
Healthpeak, Brookfield Launch $2.1B Outpatient Medical JV - Connect CRE
Healthpeak Properties and Brookfield Form a $2.1 Billion Strategic Joint Venture - AOL.com
Kirkland, Latham Guide $2.1B Healthpeak, Brookfield JV Deal - Law360
Healthpeak Properties and Brookfield form a $2.1b strategic joint venture - Institutional Real Estate, Inc.
Healthpeak Properties, Brookfield form $2.1b strategic JV - Institutional Real Estate, Inc.
Healthpeak forms $2.1 billion joint venture with Brookfield By Investing.com - Investing.com Nigeria
Healthpeak and Brookfield Form $2.1 Billion Outpatient Medical Real Estate Venture - citybiz
Healthpeak Properties Sells Brookfield Minority Stake in $2.1 Billion Portfolio - marketscreener.com
Healthpeak Properties Partners With Brookfield Asset Management in $2.1 Billion Medical Buildings Venture - marketscreener.com
Healthpeak and Brookfield form $2.1B joint venture (DOC:NYSE) - Seeking Alpha
Healthpeak forms $2.1 billion joint venture with Brookfield - Investing.com India
Healthpeak Properties And Brookfield Form A $2.1 Billion Strategic Joint Venture - TradingView
Brookfield Takes 49% Stake in 86 Outpatient Medical Buildings - Stock Titan
Healthpeak Properties stock hits 52-week high at 22.13 USD By Investing.com - Investing.com South Africa
Healthpeak Properties Inc. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch
Healthpeak Properties stock hits 52-week high at 22.13 USD - Investing.com
Healthpeak Properties (DOC) Reaffirms Dividend As Fair Value Stays In Focus - Yahoo Finance
What is Janus Living and Why is Healthpeak Spinning it Off - Kavout | AI
US40414LAR0 Bond Profile — Key Metrics - TradingView
US40414LAR0 Bond Coupon Profile — Rate & Payments - TradingView
US40414LAR0 Bond Risk Profile - TradingView
DOC Maintained by Wells Fargo -- Price Target Raised to $22.00 - GuruFocus
Wells Fargo Maintains Healthpeak Properties(DOC.US) With Hold Rating, Raises Target Price to $22 - Moomoo
PEAK4849213 Bond Profile — Key Metrics - TradingView
Finanzdaten der Healthpeak Properties Inc-Aktie (DOC)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.50%
0.20%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):